Skip to content

NANOVIRICIDES, INC.: 10-K/A filed 2013-10-08

What NANOVIRICIDES, INC. reported in its annual report amendment filed 2013-10-08 (fiscal FY 2013): 29 published measures, 104 facts as tagged in accession 0001144204-13-054370.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-K/A (annual report amendment)
Filed
2013-10-08
Fiscal period
fiscal FY 2013
Accession
0001144204-13-054370 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NANOVIRICIDES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-3016,407,554USD
At 2012-06-3015,629,808USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-308,397,902USD
At 2012-06-301,779,615USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-308,009,652USD
At 2012-06-3013,850,193USD
At 2011-06-3010,170,891USD
At 2010-06-306,518,677USD
At 2009-06-302,485,541USD
At 2008-06-30443,739USD
At 2007-06-30500,338USD
At 2006-06-301,238,456USD
At 2005-06-30-66,005USD
At 2005-04-300USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-3013,923,245USD
At 2012-06-3014,274,985USD
At 2011-06-309,224,023USD
At 2010-06-306,955,733USD
At 2005-04-300USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-06-30 to 2013-06-30-8,875,668USD366
2005-04-02 to 2013-06-30-38,299,784USD3012
2011-07-01 to 2012-06-30-6,207,207USD366
2010-06-30 to 2011-06-30-6,477,165USD366
2009-06-30 to 2010-06-30-4,744,208USD366
2008-06-30 to 2009-06-30-2,787,798USD366
2007-07-01 to 2008-06-30-2,738,337USD366
2006-06-30 to 2007-06-30-3,118,963USD366
2005-06-30 to 2006-06-30-3,284,432USD366
2005-03-31 to 2005-06-30-66,005USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-06-30 to 2013-06-30-5,797,772USD366
2005-04-02 to 2013-06-30-25,959,973USD3012
2011-07-01 to 2012-06-30-4,217,986USD366
2010-06-30 to 2011-06-30-4,507,668USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-06-30 to 2013-06-3064,931USD366
2005-04-02 to 2013-06-301,505,648USD3012
2011-07-01 to 2012-06-3023,352USD366
2010-06-30 to 2011-06-30152,961USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-06-30 to 2013-06-306,510,963USD366
2005-04-02 to 2013-06-3042,847,821USD3012
2011-07-01 to 2012-06-309,327,500USD366
2010-06-30 to 2011-06-306,970,000USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-06-30 to 2013-06-30-1,064,931USD366
2005-04-02 to 2013-06-30-2,964,603USD3012
2011-07-01 to 2012-06-30-58,552USD366
2010-06-30 to 2011-06-30-194,042USD366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-06-30 to 2013-06-300USD366
2005-04-02 to 2013-06-300USD3012
2011-07-01 to 2012-06-300USD366
2010-06-30 to 2011-06-300USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-30468,896USD
At 2012-06-30614,842USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-06-30 to 2013-06-30-6,590,379USD366
2005-04-02 to 2013-06-30-35,398,066USD3012
2011-07-01 to 2012-06-30-6,081,749USD366
2010-06-30 to 2011-06-30-6,429,455USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-3014,521,625USD
At 2012-06-3014,589,159USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-06-30 to 2013-06-30177,038USD366
2005-04-02 to 2013-06-30177,038USD3012
2011-07-01 to 2012-06-300USD366
2010-06-30 to 2011-06-300USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-301,178,184USD
At 2012-06-301,779,615USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-06-30417,033USD
At 2012-06-30425,807USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-06-30 to 2013-06-306,590,379USD366
2005-04-02 to 2013-06-3035,398,066USD3012
2011-07-01 to 2012-06-306,081,749USD366
2010-06-30 to 2011-06-306,429,455USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-06-30 to 2013-06-304,292,909USD366
2005-04-02 to 2013-06-3022,804,060USD3012
2011-07-01 to 2012-06-304,265,933USD366
2010-06-30 to 2011-06-304,155,846USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3047,026,173shares
At 2012-06-3044,460,629shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3046,259,420USD
At 2012-06-3043,227,028USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-06-301,505,648USD
At 2012-06-301,440,717USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-06-301,036,752USD
At 2012-06-30825,875USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-06-30417,033USD
At 2012-06-30425,807USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-06-30204,359USD
At 2012-06-3096,878USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-06-300USD
At 2012-06-300USD
At 2011-06-300USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-06-30 to 2013-06-30-8,875,668USD366
2005-04-02 to 2013-06-30-38,299,784USD3012
2011-07-01 to 2012-06-30-6,207,207USD366
2010-06-30 to 2011-06-30-6,477,165USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-06-30 to 2013-06-302,297,470USD366
2005-04-02 to 2013-06-3013,014,848USD3012
2011-07-01 to 2012-06-301,815,816USD366
2010-06-30 to 2011-06-302,273,609USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-06-30 to 2013-06-30210,877USD366
2005-04-02 to 2013-06-301,036,752USD3012
2011-07-01 to 2012-06-30210,877USD366
2010-06-30 to 2011-06-30518,968USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-06-30 to 2013-06-30-2,285,289USD366
2005-04-02 to 2013-06-30-2,901,718USD3012
2011-07-01 to 2012-06-30-125,458USD366
2010-06-30 to 2011-06-30-47,710USD366

Inspect the source

Entity
NANOVIRICIDES, INC. / CIK 0001379006
Captured
2026-09-20T07:58:03.748Z
SEC response SHA-256
5d15adcbc42d7ac8bfebbf748da8ae31563dd5d02e790dc3e1b9bde076c805d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001379006.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))